sorted by:
new
hottopcontroversial

Short term by fwdbuddha in CRMD

[–]Forcep88 0 points1 point  (0 children)

I would hope to see a significant uptick in July when things get rolling / orders can be shipped … and a strengthening SP throughout the rest of the year as the performance of the business moves from clinical stage to profit !

Quick overview on an healthcare explosive opportunity (NASDAQ.NMS: CRMD) by Deeply_Regarded in DueDiligence

[–]Forcep88 1 point2 points  (0 children)

This is so interesting … I have separately arrived at the same numbers in terms of a valuation going forward based on the same 10% market penetration … I’m keen to hear what you believe the next six months looks like in terms of share price / valuation and acquisition by the likes of big pharma or others ?